Jumanji has entertained audiences with its high-stakes jungle thrills since its 1995 release. While the film has spawned a ...

Celebrities have been everywhere this week. In New York City, Emily Blunt attends a screening of her film, The Smashing ...

After appearing in our Top 5 lineup for the entire awards season, she is now in seventh place for a nomination.

HBO has some incredible thriller shows that would wholly appeal to genre fans, but even with A-list casts, these series fell ...

Julianne Moore is teaming up with Lilly to encourage people to be proactive about brain health through their ongoing Brain Health Matters campaign. Julianne shares how her Oscar-winning role in "Still ...

Eli Lilly stock has soared in the triple digits over three years. Investors are excited about the company’s portfolio of weight loss drugs, which has generated blockbuster revenue. The stock recently ...

Patty was born on March 3, 1949, in Greeley, Colorado. She attended St. Peter school and then transferred to College High School (now University High); She finished her education at UNC with a BA in ...

Eli Lilly & Co.’s stock has reached new highs in recent days, becoming the first pharmaceutical company to hit a $1 trillion valuation. The surge has also lifted the founding family’s private ...

A fresh call from Bernstein has Wall Street doing a double-take. Bernstein just reset Eli Lilly’s price target. Analyst Breen cites talks about GLP-1 catalysts, robust U.S. policy, and promising ...

Philadelphia is about to become the host of the fifth Lilly Gateway Labs, a biotech incubator for early-stage companies backed by Eli Lilly & Co., writes Harold Brubaker for The Philadelphia Inquirer.

Previous mega blockbusters took years to reach their peak sales. Lilly’s tirzepatide franchise is on course to exceed them just a few years in. Eli Lilly is rewriting the rules of pharma. Not only did ...

Eli Lilly is upgraded to a "Strong Buy" due to 54% revenue growth, driven by Zepbound and Mounjaro's success in obesity and T2D. The company is expanding its pipeline with Orforglipron [oral GLP-1 ...